The biotech industry has been abuzz with the latest results from the testing of RegenxBio’s RGX-202. The promising outcomes from the study, reported in November 2024, highlight the treatment’s potential to enhance muscle function in patients, particularly in tasks like walking, rising, and stair-climbing. These positive results, based on improvements in muscle function in boys […]
